Attys Get $4.5M Of $22M Aegerion Drug Marketing Settlement
A Massachusetts federal judge on Wednesday awarded $4.45 million in fees to attorneys who secured a $22.25 million settlement to end an investor class action accusing Aegerion Pharmaceuticals Inc. of hiding...To view the full article, register now.
Already a subscriber? Click here to view full article